GUGGENHEIM CAPITAL LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$452,000
+3.2%
19,437
-29.3%
0.00%
+200.0%
Q1 2018$438,000
+14.7%
27,511
+49.6%
0.00%0.0%
Q4 2017$382,000
-23.1%
18,384
-47.0%
0.00%0.0%
Q3 2017$497,000
-10.1%
34,655
+8.3%
0.00%0.0%
Q2 2017$553,000
+120.3%
31,998
+40.4%
0.00%0.0%
Q1 2017$251,000
-1.6%
22,785
+29.9%
0.00%0.0%
Q4 2016$255,000
-29.8%
17,540
+18.6%
0.00%0.0%
Q3 2016$363,000
+17.1%
14,788
-4.0%
0.00%0.0%
Q2 2016$310,000
-63.2%
15,404
-51.9%
0.00%
-66.7%
Q1 2016$842,000
-62.4%
32,051
+45.3%
0.00%
-57.1%
Q4 2015$2,242,000
-30.9%
22,055
+21.2%
0.01%
-30.0%
Q3 2015$3,246,000
-48.1%
18,198
-35.4%
0.01%
-33.3%
Q2 2015$6,254,000
+36.8%
28,153
+22.3%
0.02%
+36.4%
Q1 2015$4,572,000
+24.2%
23,018
-10.5%
0.01%
+22.2%
Q4 2014$3,681,000
+57.4%
25,718
+44.3%
0.01%
+50.0%
Q3 2014$2,338,000
+15.5%
17,820
+11.0%
0.01%
+20.0%
Q2 2014$2,024,000
-21.2%
16,050
-17.7%
0.01%
-28.6%
Q1 2014$2,569,000
+58.1%
19,500
+40.9%
0.01%
+40.0%
Q4 2013$1,625,000
-25.7%
13,840
-34.0%
0.01%
-37.5%
Q3 2013$2,188,000
-31.6%
20,970
-42.5%
0.01%
-38.5%
Q2 2013$3,198,00036,4600.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders